BioCryst Pharmaceuticals ... (BCRX)
BioCryst Pharmaceuticals Max Pain By Strike
BCRX trades at $8.56, 7.0% above the near-term max pain of $8 expiring Sep 19, 2025 (25 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($7-$10), reflecting growing call interest at higher strikes. Key magnetic zone at 7 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
BioCryst Pharmaceuticals Max Pain By Expiry
Max pain for BCRX shows an upward trend from 7 to 10, suggesting bullish positioning in longer-dated options. The 37% spread signals divergent expectations across timeframes. Levels distributed around 8.56. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 8 | -0.56 (-6.54%) |
| Oct 17, 2025 | 8 | -0.56 (-6.54%) |
| Dec 19, 2025 | 9 | 0.44 (5.14%) |
| Jan 16, 2026 | 7 | -1.56 (-18.22%) |
| Mar 20, 2026 | 10 | 1.44 (16.82%) |
| Jan 15, 2027 | 7 | -1.56 (-18.22%) |